Serina Therapeutics Files 8-K
Ticker: SER · Form: 8-K · Filed: Apr 15, 2025 · CIK: 1708599
| Field | Detail |
|---|---|
| Company | Serina Therapeutics, Inc. (SER) |
| Form Type | 8-K |
| Filed Date | Apr 15, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: filing, financials, regulation-fd
TL;DR
Serina Therapeutics (formerly AgeX) filed an 8-K on 4/15/25 for Reg FD and financials.
AI Summary
Serina Therapeutics, Inc. filed an 8-K on April 15, 2025, to report a Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly known as AgeX Therapeutics, Inc. until June 6, 2017, is located in Huntsville, Alabama.
Why It Matters
This filing indicates Serina Therapeutics is providing updates on its financial statements and exhibits, which could contain material information for investors.
Risk Assessment
Risk Level: low — This is a routine filing for financial statements and exhibits, not indicating any immediate adverse events.
Key Players & Entities
- Serina Therapeutics, Inc. (company) — Registrant
- AgeX Therapeutics, Inc. (company) — Former company name
- April 15, 2025 (date) — Filing date
- Huntsville, Alabama (location) — Principal executive offices
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report a Regulation FD Disclosure and to file Financial Statements and Exhibits.
When was this 8-K filed?
This 8-K was filed on April 15, 2025.
What is the current name of the registrant?
The current name of the registrant is Serina Therapeutics, Inc.
What was the former name of the company?
The former name of the company was AgeX Therapeutics, Inc.
Where are Serina Therapeutics, Inc.'s principal executive offices located?
Serina Therapeutics, Inc.'s principal executive offices are located at 601 Genome Way, Suite 2001, Huntsville, Alabama 35806.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 15, 2025 regarding Serina Therapeutics, Inc. (SER).